×
Reinventing Behavioral Health During the COVID-19 Pandemic PDF
$ 40.00
Reinventing Behavioral Health During the COVID-19 Pandemic PDF quantity
$ 40.00
×
Mental Health Treatment Received by Primary Care Patients With Posttraumatic Stress Disorder PDF
$ 40.00
Mental Health Treatment Received by Primary Care Patients With Posttraumatic Stress Disorder PDF quantity
$ 40.00
×
Antidepressant-Induced Mania in Bipolar Patients: Identification of Risk Factors PDF
$ 40.00
Antidepressant-Induced Mania in Bipolar Patients: Identification of Risk Factors PDF quantity
$ 40.00
×
Prodromal Symptoms of Relapse in a Sample of Egyptian Schizophrenic Patients PDF
$ 40.00
Prodromal Symptoms of Relapse in a Sample of Egyptian Schizophrenic Patients PDF quantity
$ 40.00
×
A Randomized Controlled Trial of Community-Delivered Heated Hatha Yoga for Moderate-to-Severe Depression PDF
$ 40.00
A Randomized Controlled Trial of Community-Delivered Heated Hatha Yoga for Moderate-to-Severe Depression PDF quantity
$ 40.00
×
Treatment of Binge-Eating Disorder With Topiramate: A Clinical Case Series PDF
$ 40.00
Treatment of Binge-Eating Disorder With Topiramate: A Clinical Case Series PDF quantity
$ 40.00
×
Ethnic Differences in Mental Illness Severity: A Population-Based Study of Chinese and South Asian Patients in Ontario, Canada PDF
$ 40.00
Ethnic Differences in Mental Illness Severity: A Population-Based Study of Chinese and South Asian Patients in Ontario, Canada PDF quantity
$ 40.00
×
A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder PDF
$ 40.00
A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder PDF quantity
$ 40.00
×
The Brief Psychiatric Rating Scale as an Acute Inpatient Outcome Measurement Tool: A Pilot Study PDF
$ 40.00
The Brief Psychiatric Rating Scale as an Acute Inpatient Outcome Measurement Tool: A Pilot Study PDF quantity
$ 40.00
×
Inflammatory Markers and Brain-Derived Neurotrophic Factor as Potential Bridges Linking Bipolar Disorder and Cardiovascular Risk Among Adolescents PDF
$ 40.00
Inflammatory Markers and Brain-Derived Neurotrophic Factor as Potential Bridges Linking Bipolar Disorder and Cardiovascular Risk Among Adolescents PDF quantity
$ 40.00
×
Community Mental Health Care in the COVID-19 Response: An Italian Example PDF
$ 40.00
Community Mental Health Care in the COVID-19 Response: An Italian Example PDF quantity
$ 40.00
×
Tiagabine for Posttraumatic Stress Disorder: A Case Series of 7 Women PDF
$ 40.00
Tiagabine for Posttraumatic Stress Disorder: A Case Series of 7 Women PDF quantity
$ 40.00
×
To Use or Not? Evaluating ASPECTS of Smartphone Apps and Mobile Technology for Clinical Care in Psychiatry PDF
$ 40.00
To Use or Not? Evaluating ASPECTS of Smartphone Apps and Mobile Technology for Clinical Care in Psychiatry PDF quantity
$ 40.00
×
Obesity and Associated Complications in Patients With Severe Mental Illnesses: A Cross-Sectional Survey PDF
$ 40.00
Obesity and Associated Complications in Patients With Severe Mental Illnesses: A Cross-Sectional Survey PDF quantity
$ 40.00
×
An Open-Label Study of the Treatment Efficacy of Olanzapine for Tourette's Disorder PDF
$ 40.00
An Open-Label Study of the Treatment Efficacy of Olanzapine for Tourette's Disorder PDF quantity
$ 40.00
×
The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia PDF
$ 40.00
The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia PDF quantity
$ 40.00
×
Pharmacologic Treatment of Anxiety Disorders in 1989 Versus 1996: Results From the Harvard/Brown Anxiety Disorders Research Program PDF
$ 40.00
Pharmacologic Treatment of Anxiety Disorders in 1989 Versus 1996: Results From the Harvard/Brown Anxiety Disorders Research Program PDF quantity
$ 40.00
×
CYP2D6 Genotyping and Inhibition as Predictors of Adverse Drug Reactions in Depressive Disorders PDF
$ 40.00
CYP2D6 Genotyping and Inhibition as Predictors of Adverse Drug Reactions in Depressive Disorders PDF quantity
$ 40.00
×
A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression PDF
$ 40.00
A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression PDF quantity
$ 40.00
×
Short-Term Naturalistic Treatment Outcomes in Cigarette Smokers With Substance Abuse and/or Mental Illness. PDF
$ 40.00
Short-Term Naturalistic Treatment Outcomes in Cigarette Smokers With Substance Abuse and/or Mental Illness. PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart